Abstract
Objective:
This retrospective analysis assessed the relationship between medical treatment (postnatal steroids, surfactant) received neonatally and outcomes at 3 and 8 years using a longitudinal sample of children with bronchopulmonary dysplasia (BPD).
Study Design:
Four groups were formed retrospectively based on the type of neonatal medical treatment received: no drug intervention (n=37), surfactant only (n=29), postnatal steroids only (n=13) and combined surfactant and postnatal steroids (n=16). Groups were compared on neurological and medical outcomes.
Result:
Combined postnatal steroids and surfactant treatment was associated with more days on supplemental oxygen than no intervention or surfactant only. Surfactant replacement therapy alone was not associated with adverse consequences; however, postnatal steroid exposure appeared to be related.
Conclusion:
Although retrospective analyses make statements about causation impossible, the differential relationships of therapies with cognitive outcomes argues for careful monitoring of therapeutic agents with very low birth weight infants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boynton BR . The epidemiology of bronchopulmonary dysplasia. Bronchopulmonary Dysplasia 1988; 4: 19–32.
Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.
Northway Jr WH, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323: 1793–1799.
Walsh MC, Yao Q, Horbar JD, Carpenter JH, Lee SK, Ohlsson A . Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 2006; 118: e1328–e1335.
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353–1360.
Kumar P, Kiran PS . Changing trends in the management of respiratory distress syndrome (RDS). Indian J Pediatr 2004; 71: 49–54.
Thorp JA, Jones PG, Peabody JL, Knox E, Clark RH . Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery. Obstet Gynecol 2002; 99: 109–115.
Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network 2001, pp. 95–101.
American Academy of Pediatrics, Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330–338.
Halliday HL, Ehrenkranz RA . Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001; (2): CD001145.
Halliday HL, Ehrenkranz RA, Doyle LW . Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; (1): CD001144.
Halliday HL, Ehrenkranz RA, Doyle LW . Early postnatal (<96 h) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; (1): CD001146.
Ramsay PL, O’Brian Smith E, Hegemier S, Welty SE . Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Pediatrics 1998; 102: 927–932.
D’Angio CT, Sinkin RA, Stevens TP, Landfish NK, Merzbach JL, Ryan RM et al. Longitudinal, 15-year follow-up of children born at less than 29 weeks’ gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. Pediatrics 2002; 110: 1094–1102.
Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD, MD for National Institute of Child Health and Human Development Neonatal Research Network. Changes in neurodevelopmental outcomes at 18 to 22 months’ corrected age among infants of less than 25 weeks’ gestational age born in 1993–1999. Pediatrics 2005; 115: 1645–1651.
Sinn JKH, Ward MC, Henderson-Smart DJ . Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health 2002; 38: 597–600.
Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: e359.
Singer LT, Martin RJ, Hawkins SW, Benson-Szekely LJ, Yamashita TS, Carlo WA . Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. Pediatrics 1992; 90: 380–384.
Singer L, Yamashita T, Lilien L, Collin M, Baley J . A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997; 100: 987–993.
Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529–534.
Bayley N . Bayley Scales of Infant Development. 2nd ed. The Psychological Corporation: San Antonio, 1993.
Newborg J, Stock JR, Wnek L . Battelle Developmental Inventory. DLM Teaching Resources: Allen, TX, 1988.
Caldwell B, Bradley R . Home Observation for Measurement of the Environment. University of Arkansas: Little Rock, AK, 1984.
Wechsler D . Wechsler Intelligence Scale for Children. 3rd ed. Psychological Corporation: San Antonio, TX, 1991.
Woodcock RW, Mather N . Woodcock-Johnson Test of Achievement Revised: Standard and Supplemental Battery. DLM Teaching Resources: Allen, TX, 1987.
Semel E, Wiig E, Secord W, Sabers D . Clinical Evaluation of Language Fundamentals. 3rd ed. Psychological Corp.: New York, NY, 1995.
Robertson CM, Etches PC, Goldson E, Kyle JM . Eight-year school performance, neurodevelopmental, and growth outcome of neonates with bronchopulmonary dysplasia: a comparative study. Pediatrics 1992; 89: 365–372.
Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, Coates AL . Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol 2000; 42: 53–60.
Hollingshead AB . Two Factor Index of Social Position. Yale University: New Haven, CT, 1957.
Rushing S, Ment LR . Preterm birth: a cost benefit analysis. Semin Perinatol 2004; 28: 444–450.
Acknowledgements
Support was provided by grants MCJ-390592, MC-00127 and MC-00334 from the Maternal and Child Health Program, Health Resources and Services Administration, Department of Health and Human Services, Rockville, MD. We thank Terri Lotz-Ganley for her assistance on this project and the families for their continued participation. Support was provided by grants MCJ-390592, MC-00127 and MC-00334 from the Maternal and Child Health Program, Health Resources and Services Administration, Department of Health and Human Services, Rockville, MD.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Short, E., Kirchner, H., Asaad, G. et al. Long-term sequelae of postnatal surfactant and corticosteroid therapies for BPD. J Perinatol 28, 498–504 (2008). https://doi.org/10.1038/jp.2008.30
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2008.30